NEW YORK, Oct. 9 - Orchid BioSciences has tapped George Poste to be its new chairman. He replaces Dale Pfost, who remains as Orchid's president and CEO.

Poste, 58, is the former president of R&D and chief science and technology officer at SmithKline Beecham, and current CEO of Health Technology Networks. He has been a member of Orchid's board of directors since April 2000.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.